Curtiss-Wright CW holder plans 688-share NYSE sale under Form 144

Rhea-AI Filing Summary

Curtiss-Wright (CW)Merrill, located at 6000 Fairview Rd., Suite 600, Charlotte, NC 28210, on the NYSE around 11/25/2025, with an aggregate market value of $391,472. The filing states that there were 36,847,638 shares of this class outstanding.

The shares to be sold were originally acquired from the company as stock-based compensation. One grant of common stock was acquired on 02/07/2024 as a stock bonus for 400 shares, and another on 03/18/2024 as a stock bonus for 288 shares, with both transactions described as stock bonus payments on their respective dates.

11/25/2025 - 10:48 AM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 6000 Fairview Rd. Ste 600 Charlotte NC 28210	688	391472	36847638	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/07/2024	Stock bonus	Company			400	02/07/2024	Stock Bonus
Common	03/18/2024	Stock bonus	Company			288	03/18/2024	Stock bonus

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Curtiss-Wright (CW) disclose in this Form 144 filing?

The Form 144 reports a planned sale of 688 shares of Curtiss-Wright common stock on the NYSE, to be executed through Merrill around 11/25/2025.

How many Curtiss-Wright (CW) shares are planned to be sold and what is their value?

The filing covers 688 common shares with an aggregate market value of $391,472 as stated in the form.

How were the Curtiss-Wright (CW) shares in this Form 144 originally acquired?

The shares were acquired from the company as stock-based compensation: 400 shares on 02/07/2024 and 288 shares on 03/18/2024, both described as stock bonuses.

How many Curtiss-Wright (CW) common shares were outstanding according to the Form 144?

The Form 144 states that there were 36,847,638 Curtiss-Wright common shares outstanding for this class of securities.

On which exchange and through which broker will the Curtiss-Wright (CW) shares be sold?

The Form 144 indicates the shares may be sold on the NYSE through Merrill, at its office at 6000 Fairview Rd., Suite 600, Charlotte, NC 28210.

What type of securities are covered by this Curtiss-Wright (CW) Form 144?

The filing relates to common stock of Curtiss-Wright, listed with the NYSE as the named securities exchange.